Long-term suppression of testosterone after treatment with a gonadotropin-releasing hormone agonist in a woman with a presumed testosterone secreting ovarian tumor

J Clin Endocrinol Metab. 1997 Jun;82(6):1746-8. doi: 10.1210/jcem.82.6.3975.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Antineoplastic Agents, Hormonal / therapeutic use*
  • Delayed-Action Preparations
  • Female
  • Gonadotropin-Releasing Hormone / agonists*
  • Hirsutism / etiology
  • Humans
  • Leuprolide / therapeutic use*
  • Middle Aged
  • Ovarian Neoplasms / complications
  • Ovarian Neoplasms / drug therapy*
  • Ovarian Neoplasms / metabolism*
  • Testosterone / antagonists & inhibitors*
  • Testosterone / metabolism*
  • Time Factors

Substances

  • Antineoplastic Agents, Hormonal
  • Delayed-Action Preparations
  • Gonadotropin-Releasing Hormone
  • Testosterone
  • Leuprolide